Trinity Biotech Operating Expenses 2010-2025 | TRIB

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Trinity Biotech operating expenses from 2010 to 2025. Operating expenses can be defined as the sum of all operating expenses for the given industry.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Trinity Biotech operating expenses from 2010 to 2025. Operating expenses can be defined as the sum of all operating expenses for the given industry.

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$228.4B
Boston Scientific (BSX)	$153.7B
Stryker (SYK)	$149.1B
EssilorLuxottica (ESLOY)	$146B
Medtronic (MDT)	$115.2B
Lonza Group Ag (LZAGY)	$48.5B
Haleon (HLN)	$43.7B
ResMed (RMD)	$41.9B
Agilent Technologies (A)	$34.1B
GE HealthCare Technologies (GEHC)	$33.8B
Terumo (TRUMY)	$27.8B
Koninklijke Philips (PHG)	$26.5B
Insulet (PODD)	$23.1B
Zimmer Biomet Holdings (ZBH)	$20.7B
Smith & Nephew SNATS (SNN)	$16.2B
Baxter (BAX)	$12.5B
Sunny Optical Technology (SNPTF)	$10.8B
Demant (WILYY)	$8.1B
Bio-Rad Laboratories (BIO)	$7.8B
Lantheus Holdings (LNTH)	$3.7B
Shandong Weigao Medical Polymer (SHWGF)	$3.5B
Envista Holdings (NVST)	$3.4B
Perrigo (PRGO)	$3.2B
Prestige Consumer Healthcare (PBH)	$3.2B
ICU Medical (ICUI)	$3.1B
Haemonetics (HAE)	$2.6B
LeMaitre Vascular (LMAT)	$2.2B
QuidelOrtho (QDEL)	$1.8B
AtriCure (ATRC)	$1.8B
Curaleaf Holdings (CURLF)	$1.7B